UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features

Journal of neurology, neurosurgery and psychiatry, 2018-05, Vol.89 (5), p.499-505

2018

Volltextzugriff (PDF)

Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic

Frontiers in immunology, 2023, Vol.14, p.1004795-1004795

2023

Volltextzugriff (PDF)

Visual field loss and structure–function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody

Multiple sclerosis, 2021-05, Vol.27 (6), p.855-863

2021

Volltextzugriff (PDF)

A novel method of inducing endogenous pupil oscillations to detect patients with unilateral optic neuritis

PloS one, 2018-08, Vol.13 (8), p.e0201730-e0201730

2018

Volltextzugriff (PDF)

SARS-CoV-2-associated encephalitis: arguments for a post-infectious mechanism

Critical care (London, England), 2020-11, Vol.24 (1), p.658-658, Article 658

2020

Volltextzugriff (PDF)

Generalization of ocular myasthenia gravis 10 years after onset

Journal of neurology, 2022-12, Vol.269 (12), p.6597-6604

2022

Volltextzugriff (PDF)

Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis

Ocular immunology and inflammation, 2022-05, Vol.30 (4), p.821-828

2022

Volltextzugriff (PDF)

Plasma exchange response in 34 patients with severe optic neuritis

Journal of neurology, 2016-05, Vol.263 (5), p.883-887

2016

Volltextzugriff (PDF)

Risk of generalization in ocular myasthenia gravis after 10 years. (4778)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Natalizumab extended-interval dosing in a real-life setting

Journal of the neurological sciences, 2023-07, Vol.450, p.120689-120689, Article 120689

2023

Volltextzugriff (PDF)

Taux de rétention du premier traitement de fond chez les patients SEP RR naïfs

Revue neurologique, 2020-09, Vol.176, p.S126-S126

2020

Volltextzugriff (PDF)

Reply to “Axonal hyperexcitability due to Schwann cell involvement in chronic progressive external ophthalmoplegia”

Clinical neurophysiology, 2017-10, Vol.128 (10), p.2098-2098

2017

Volltextzugriff (PDF)

Contrast-Enhanced 3D Spin Echo T1-Weighted Sequence Outperforms 3D Gradient Echo T1-Weighted Sequence for the Detection of Multiple Sclerosis Lesions on 3.0 T Brain MRI

Investigative radiology, 2023-05, Vol.58 (5), p.314-319

2023

Volltextzugriff (PDF)

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy

Neurology, 2013-06, Vol.80 (24), p.2217-2225

2013

Volltextzugriff (PDF)

Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies

Journal of neurology, neurosurgery and psychiatry, 2020-01, Vol.91 (1), p.49-57

2020

Volltextzugriff (PDF)

Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2014-09, Vol.85 (9), p.1038-1040

2014

Volltextzugriff (PDF)

Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial

JAMA neurology, 2021-04, Vol.78 (4), p.426

2021

Volltextzugriff (PDF)

Extension de l’intervalle de traitement par natalizumab : étude en vie réelle

Revue neurologique, 2023-04, Vol.179, p.S171-S171

2023

Volltextzugriff (PDF)

Réactivations de scléroses en plaques à l’arrêt d’un traitement par fingolimod pour désir de grossesse : une expérience monocentrique

Revue neurologique, 2023-04, Vol.179, p.S148-S148

2023

Volltextzugriff (PDF)

Ethical Management of COVID-19 Pandemic at a Neurological Hospital: The Ethicovid Report

Journal of neurosurgical anesthesiology, 2023-10, Vol.35 (4), p.417-422

2023

Volltextzugriff (PDF)

Prospective longitudinal study on prognostic factors of visual recovery and structural change after a first episode of optic neuritis

European journal of neurology, 2022-09, Vol.29 (9), p.2781-2791

2022

Volltextzugriff (PDF)

First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?

Stroke (1970), 2015-08, Vol.46 (8), p.2315-2317

2015

Volltextzugriff (PDF)

Anti‐disialosyl‐immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study

European journal of neurology, 2022-12, Vol.29 (12), p.3547-3555

2022

Volltextzugriff (PDF)

Dimethylfumarate in Real-Life: Efficacy and Safety in a Monocentric Prospective Cohort of 156 Patients with MS (P3.060)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy

Journal of the neurological sciences, 2010-05, Vol.292 (1), p.63-71

2010

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features

Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic

Visual field loss and structure–function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody

A novel method of inducing endogenous pupil oscillations to detect patients with unilateral optic neuritis

SARS-CoV-2-associated encephalitis: arguments for a post-infectious mechanism

Generalization of ocular myasthenia gravis 10 years after onset

Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis

Plasma exchange response in 34 patients with severe optic neuritis

Risk of generalization in ocular myasthenia gravis after 10 years. (4778)

Natalizumab extended-interval dosing in a real-life setting

Taux de rétention du premier traitement de fond chez les patients SEP RR naïfs

Reply to “Axonal hyperexcitability due to Schwann cell involvement in chronic progressive external ophthalmoplegia”

Contrast-Enhanced 3D Spin Echo T1-Weighted Sequence Outperforms 3D Gradient Echo T1-Weighted Sequence for the Detection of Multiple Sclerosis Lesions on 3.0 T Brain MRI

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy

Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies

Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis

Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial

Extension de l’intervalle de traitement par natalizumab : étude en vie réelle

Réactivations de scléroses en plaques à l’arrêt d’un traitement par fingolimod pour désir de grossesse : une expérience monocentrique

Ethical Management of COVID-19 Pandemic at a Neurological Hospital: The Ethicovid Report

Prospective longitudinal study on prognostic factors of visual recovery and structural change after a first episode of optic neuritis

First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?

Anti‐disialosyl‐immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study

Dimethylfumarate in Real-Life: Efficacy and Safety in a Monocentric Prospective Cohort of 156 Patients with MS (P3.060)

Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy

Suchergebnisse filtern